

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.04168326 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.68994612 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.68994612 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.31758336 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.31758336 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 7.30756624 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 7.20103072 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.90440600 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.37549376 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.27362276 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.27362276 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.27362276 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.14314798 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.98902286 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.89763463 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.78953601 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.70365868 |
| 18 | urea cycle (GO:0000050) | 5.67370661 |
| 19 | urea metabolic process (GO:0019627) | 5.67370661 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.60827528 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.56585186 |
| 22 | regulation of fibrinolysis (GO:0051917) | 5.42990348 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.39702839 |
| 24 | protein carboxylation (GO:0018214) | 5.39702839 |
| 25 | cysteine metabolic process (GO:0006534) | 5.38347572 |
| 26 | regulation of protein activation cascade (GO:2000257) | 5.37234929 |
| 27 | regulation of plasminogen activation (GO:0010755) | 5.35220229 |
| 28 | complement activation, alternative pathway (GO:0006957) | 5.31526202 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 5.31420066 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.20958491 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 5.13921949 |
| 32 | bile acid metabolic process (GO:0008206) | 5.12832258 |
| 33 | drug metabolic process (GO:0017144) | 5.07490546 |
| 34 | oxidative demethylation (GO:0070989) | 5.03678032 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 5.00272353 |
| 36 | intestinal cholesterol absorption (GO:0030299) | 5.00167420 |
| 37 | regulation of complement activation (GO:0030449) | 4.99777000 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.91205168 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 4.86696436 |
| 40 | acute-phase response (GO:0006953) | 4.86213100 |
| 41 | reverse cholesterol transport (GO:0043691) | 4.84847466 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.84704523 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.80188252 |
| 44 | negative regulation of protein activation cascade (GO:2000258) | 4.80047931 |
| 45 | homocysteine metabolic process (GO:0050667) | 4.77638835 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.76766496 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.76766496 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.76766496 |
| 49 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.69454234 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.68388505 |
| 51 | negative regulation of blood coagulation (GO:0030195) | 4.62438399 |
| 52 | negative regulation of hemostasis (GO:1900047) | 4.62438399 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.62382913 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.62382913 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.59612284 |
| 56 | phospholipid efflux (GO:0033700) | 4.58926842 |
| 57 | regulation of humoral immune response (GO:0002920) | 4.58484334 |
| 58 | lysine metabolic process (GO:0006553) | 4.57546464 |
| 59 | lysine catabolic process (GO:0006554) | 4.57546464 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 4.50458850 |
| 61 | bile acid and bile salt transport (GO:0015721) | 4.45930869 |
| 62 | coenzyme catabolic process (GO:0009109) | 4.44790982 |
| 63 | * acylglycerol homeostasis (GO:0055090) | 4.44713240 |
| 64 | * triglyceride homeostasis (GO:0070328) | 4.44713240 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 4.44541538 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.43966109 |
| 67 | glycine metabolic process (GO:0006544) | 4.43827815 |
| 68 | ethanol metabolic process (GO:0006067) | 4.43809291 |
| 69 | plasma lipoprotein particle clearance (GO:0034381) | 4.37112399 |
| 70 | cellular biogenic amine catabolic process (GO:0042402) | 4.36451380 |
| 71 | amine catabolic process (GO:0009310) | 4.36451380 |
| 72 | glutamate metabolic process (GO:0006536) | 4.32984266 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 4.28985795 |
| 74 | negative regulation of coagulation (GO:0050819) | 4.26712139 |
| 75 | cholesterol efflux (GO:0033344) | 4.25895422 |
| 76 | cellular glucuronidation (GO:0052695) | 4.24202614 |
| 77 | serine family amino acid metabolic process (GO:0009069) | 4.18353904 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 4.16669883 |
| 79 | ethanol oxidation (GO:0006069) | 4.13580596 |
| 80 | negative regulation of wound healing (GO:0061045) | 4.12943125 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09304339 |
| 82 | cellular modified amino acid catabolic process (GO:0042219) | 4.08352794 |
| 83 | positive regulation of blood coagulation (GO:0030194) | 4.06785808 |
| 84 | positive regulation of hemostasis (GO:1900048) | 4.06785808 |
| 85 | low-density lipoprotein particle remodeling (GO:0034374) | 4.04235619 |
| 86 | serine family amino acid biosynthetic process (GO:0009070) | 4.03231210 |
| 87 | plasma lipoprotein particle assembly (GO:0034377) | 4.01002531 |
| 88 | arginine metabolic process (GO:0006525) | 4.00999391 |
| 89 | fibrinolysis (GO:0042730) | 4.00303977 |
| 90 | aldehyde catabolic process (GO:0046185) | 4.00185348 |
| 91 | regulation of apoptotic cell clearance (GO:2000425) | 3.99687188 |
| 92 | drug catabolic process (GO:0042737) | 3.97354334 |
| 93 | S-adenosylmethionine metabolic process (GO:0046500) | 3.91392456 |
| 94 | alkaloid metabolic process (GO:0009820) | 3.89400144 |
| 95 | regulation of bile acid biosynthetic process (GO:0070857) | 3.86505747 |
| 96 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.86118346 |
| 97 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.86118346 |
| 98 | negative regulation of complement activation (GO:0045916) | 3.86105395 |
| 99 | ketone body metabolic process (GO:1902224) | 3.84611266 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 3.83940297 |
| 101 | protein-lipid complex subunit organization (GO:0071825) | 3.83087998 |
| 102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.80869984 |
| 103 | cofactor catabolic process (GO:0051187) | 3.80599883 |
| 104 | phenylpropanoid metabolic process (GO:0009698) | 3.79728725 |
| 105 | complement activation, classical pathway (GO:0006958) | 3.79439684 |
| 106 | regulation of cholesterol homeostasis (GO:2000188) | 3.78714041 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.77336869 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.77336869 |
| 109 | phospholipid homeostasis (GO:0055091) | 3.76103316 |
| 110 | positive regulation of coagulation (GO:0050820) | 3.75453673 |
| 111 | uronic acid metabolic process (GO:0006063) | 3.75166227 |
| 112 | glucuronate metabolic process (GO:0019585) | 3.75166227 |
| 113 | positive regulation of lipid catabolic process (GO:0050996) | 3.74336740 |
| 114 | complement activation (GO:0006956) | 3.74272042 |
| 115 | carboxylic acid catabolic process (GO:0046395) | 3.73900805 |
| 116 | organic acid catabolic process (GO:0016054) | 3.73900805 |
| 117 | cholesterol homeostasis (GO:0042632) | 3.73306053 |
| 118 | negative regulation of lipase activity (GO:0060192) | 3.73169933 |
| 119 | protein activation cascade (GO:0072376) | 3.72920024 |
| 120 | acetyl-CoA metabolic process (GO:0006084) | 3.68833332 |
| 121 | sterol homeostasis (GO:0055092) | 3.67032131 |
| 122 | short-chain fatty acid metabolic process (GO:0046459) | 3.64600040 |
| 123 | acute inflammatory response (GO:0002526) | 3.64329631 |
| 124 | cytolysis (GO:0019835) | 3.63239110 |
| 125 | plasma lipoprotein particle organization (GO:0071827) | 3.62959004 |
| 126 | flavonoid metabolic process (GO:0009812) | 3.61914859 |
| 127 | opsonization (GO:0008228) | 3.61843867 |
| 128 | protein-lipid complex assembly (GO:0065005) | 3.59942002 |
| 129 | NAD biosynthetic process (GO:0009435) | 3.58535767 |
| 130 | sodium-independent organic anion transport (GO:0043252) | 3.52788888 |
| 131 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.52356574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.42577090 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.22925500 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.02962906 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52139451 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.32573054 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.01068432 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.69673160 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.09521569 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.89532822 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06964150 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9872828 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.93224831 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92299694 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62948132 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.60302022 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52454516 |
| 17 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41750845 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35715280 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29270524 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21434209 |
| 21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20637003 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16372602 |
| 23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.15112528 |
| 24 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14775222 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.10731714 |
| 26 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.06791158 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04540650 |
| 28 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03591730 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03089749 |
| 30 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.01963598 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01036903 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00069965 |
| 33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99994979 |
| 34 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97566703 |
| 35 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97520585 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96063894 |
| 37 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92890888 |
| 38 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91763845 |
| 39 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91763845 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90432355 |
| 41 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89621566 |
| 42 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.89470438 |
| 43 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.88061536 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.87420682 |
| 45 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85455895 |
| 46 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.84885980 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83764068 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83162439 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.81625780 |
| 50 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.80919757 |
| 51 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.80613653 |
| 52 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79144142 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.78870575 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.78617943 |
| 55 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78467968 |
| 56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78246002 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76620592 |
| 58 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.76390869 |
| 59 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75856288 |
| 60 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.75759873 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75405019 |
| 62 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.74494990 |
| 63 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74016372 |
| 64 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73450896 |
| 65 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73329068 |
| 66 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.72659240 |
| 67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72655846 |
| 68 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.72253465 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.70765302 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70732360 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70058795 |
| 72 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.69345541 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69123529 |
| 74 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.68614282 |
| 75 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.68451521 |
| 76 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.68154609 |
| 77 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.68030146 |
| 78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.67794898 |
| 79 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67658631 |
| 80 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.67654632 |
| 81 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67569196 |
| 82 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.67271460 |
| 83 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.66972961 |
| 84 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.66875939 |
| 85 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.66687137 |
| 86 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.66305402 |
| 87 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.66176155 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.64945109 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64294214 |
| 90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64294214 |
| 91 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.64078588 |
| 92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.63796515 |
| 93 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63297639 |
| 94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59999645 |
| 95 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59100097 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.57726057 |
| 97 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57664536 |
| 98 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57654734 |
| 99 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.56025090 |
| 100 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.55398811 |
| 101 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54905616 |
| 102 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54455256 |
| 103 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52879015 |
| 104 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52848860 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52769425 |
| 106 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.51324559 |
| 107 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50786347 |
| 108 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50763076 |
| 109 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50737708 |
| 110 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50284737 |
| 111 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49730618 |
| 112 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.48729782 |
| 113 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48370031 |
| 114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.46406329 |
| 115 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45990273 |
| 116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.44131976 |
| 117 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.43462957 |
| 118 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43059372 |
| 119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42645286 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42315847 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42291032 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41921182 |
| 123 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41616142 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40985524 |
| 125 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.40343786 |
| 126 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.39837382 |
| 127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.39158633 |
| 128 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.38952924 |
| 129 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38920979 |
| 130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38443350 |
| 131 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38353961 |
| 132 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38300620 |
| 133 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38178942 |
| 134 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38170424 |
| 135 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.37080100 |
| 136 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.36257184 |
| 137 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35908723 |
| 138 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35694964 |
| 139 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35066059 |
| 140 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.34638346 |
| 141 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34152356 |
| 142 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.33977896 |
| 143 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.32367163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.34772200 |
| 2 | MP0005360_urolithiasis | 7.51012815 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.46973977 |
| 4 | MP0005365_abnormal_bile_salt | 6.19419392 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.18322596 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.27493683 |
| 7 | MP0003252_abnormal_bile_duct | 3.96788963 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.60670590 |
| 9 | MP0009840_abnormal_foam_cell | 3.28530472 |
| 10 | MP0005083_abnormal_biliary_tract | 3.10410850 |
| 11 | MP0003195_calcinosis | 2.88032319 |
| 12 | MP0005332_abnormal_amino_acid | 2.72609272 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59604083 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.26278598 |
| 15 | MP0000609_abnormal_liver_physiology | 2.17730846 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.13428941 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.11014174 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.92139867 |
| 19 | MP0003868_abnormal_feces_composition | 1.89137553 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82070633 |
| 21 | MP0001764_abnormal_homeostasis | 1.68796592 |
| 22 | MP0009697_abnormal_copulation | 1.61173337 |
| 23 | MP0003011_delayed_dark_adaptation | 1.58877260 |
| 24 | MP0005451_abnormal_body_composition | 1.49872227 |
| 25 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.46849356 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.25785867 |
| 27 | MP0003186_abnormal_redox_activity | 1.21729889 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.18414666 |
| 29 | MP0000598_abnormal_liver_morphology | 1.16854445 |
| 30 | MP0005647_abnormal_sex_gland | 1.15687435 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.12664339 |
| 32 | MP0000604_amyloidosis | 1.07913514 |
| 33 | MP0009764_decreased_sensitivity_to | 1.06272763 |
| 34 | MP0009763_increased_sensitivity_to | 1.02534729 |
| 35 | MP0002254_reproductive_system_inflammat | 1.02369009 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.02364758 |
| 37 | MP0003122_maternal_imprinting | 0.97073596 |
| 38 | MP0003879_abnormal_hair_cell | 0.97012944 |
| 39 | MP0005167_abnormal_blood-brain_barrier | 0.90664160 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 0.89240441 |
| 41 | MP0008469_abnormal_protein_level | 0.86791365 |
| 42 | MP0000566_synostosis | 0.86261308 |
| 43 | * MP0009642_abnormal_blood_homeostasis | 0.85266907 |
| 44 | MP0005408_hypopigmentation | 0.84401010 |
| 45 | MP0001915_intracranial_hemorrhage | 0.83653100 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 0.79927882 |
| 47 | MP0005376_homeostasis/metabolism_phenot | 0.79850261 |
| 48 | MP0005058_abnormal_lysosome_morphology | 0.79649502 |
| 49 | MP0005084_abnormal_gallbladder_morpholo | 0.79069829 |
| 50 | MP0009765_abnormal_xenobiotic_induced | 0.77950917 |
| 51 | MP0005670_abnormal_white_adipose | 0.77211187 |
| 52 | * MP0002078_abnormal_glucose_homeostasis | 0.75210534 |
| 53 | MP0002876_abnormal_thyroid_physiology | 0.74398689 |
| 54 | MP0002971_abnormal_brown_adipose | 0.73971760 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 0.73646920 |
| 56 | MP0005334_abnormal_fat_pad | 0.71003097 |
| 57 | MP0001661_extended_life_span | 0.67921569 |
| 58 | MP0002282_abnormal_trachea_morphology | 0.67274791 |
| 59 | MP0003172_abnormal_lysosome_physiology | 0.66683469 |
| 60 | MP0002089_abnormal_postnatal_growth/wei | 0.66604060 |
| 61 | MP0005535_abnormal_body_temperature | 0.66558535 |
| 62 | MP0005266_abnormal_metabolism | 0.65619172 |
| 63 | MP0009785_altered_susceptibility_to | 0.65610611 |
| 64 | MP0003690_abnormal_glial_cell | 0.65572716 |
| 65 | MP0004130_abnormal_muscle_cell | 0.65504275 |
| 66 | MP0006054_spinal_hemorrhage | 0.64448646 |
| 67 | MP0003329_amyloid_beta_deposits | 0.63381155 |
| 68 | MP0009053_abnormal_anal_canal | 0.61568427 |
| 69 | MP0000639_abnormal_adrenal_gland | 0.60522117 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 0.59559885 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 0.59041012 |
| 72 | MP0001756_abnormal_urination | 0.55828893 |
| 73 | MP0005448_abnormal_energy_balance | 0.55483708 |
| 74 | MP0004043_abnormal_pH_regulation | 0.54513165 |
| 75 | MP0003950_abnormal_plasma_membrane | 0.54511892 |
| 76 | MP0005464_abnormal_platelet_physiology | 0.53427868 |
| 77 | MP0003718_maternal_effect | 0.51355854 |
| 78 | MP0005395_other_phenotype | 0.50946126 |
| 79 | MP0002822_catalepsy | 0.49574219 |
| 80 | MP0002928_abnormal_bile_duct | 0.48917136 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 0.48466030 |
| 82 | MP0005164_abnormal_response_to | 0.47313096 |
| 83 | MP0006292_abnormal_olfactory_placode | 0.46329654 |
| 84 | MP0008874_decreased_physiological_sensi | 0.46052981 |
| 85 | MP0008873_increased_physiological_sensi | 0.43814481 |
| 86 | MP0003638_abnormal_response/metabolism_ | 0.43517193 |
| 87 | MP0003436_decreased_susceptibility_to | 0.43406569 |
| 88 | MP0003878_abnormal_ear_physiology | 0.43165193 |
| 89 | MP0005377_hearing/vestibular/ear_phenot | 0.43165193 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.42736322 |
| 91 | MP0005248_abnormal_Harderian_gland | 0.42590593 |
| 92 | MP0003724_increased_susceptibility_to | 0.41867933 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.40903231 |
| 94 | MP0005410_abnormal_fertilization | 0.40808081 |
| 95 | MP0003075_altered_response_to | 0.39723575 |
| 96 | * MP0003953_abnormal_hormone_level | 0.38660077 |
| 97 | MP0004381_abnormal_hair_follicle | 0.38057695 |
| 98 | MP0005166_decreased_susceptibility_to | 0.37774114 |
| 99 | MP0000579_abnormal_nail_morphology | 0.37377341 |
| 100 | MP0008872_abnormal_physiological_respon | 0.37223030 |
| 101 | MP0002090_abnormal_vision | 0.35862460 |
| 102 | MP0009672_abnormal_birth_weight | 0.35581203 |
| 103 | MP0005666_abnormal_adipose_tissue | 0.34630055 |
| 104 | MP0005187_abnormal_penis_morphology | 0.34228510 |
| 105 | MP0000371_diluted_coat_color | 0.33835834 |
| 106 | MP0005023_abnormal_wound_healing | 0.33414327 |
| 107 | MP0006082_CNS_inflammation | 0.33078037 |
| 108 | MP0003633_abnormal_nervous_system | 0.32452898 |
| 109 | MP0009115_abnormal_fat_cell | 0.31748479 |
| 110 | MP0002168_other_aberrant_phenotype | 0.31634300 |
| 111 | MP0002933_joint_inflammation | 0.31355108 |
| 112 | MP0000230_abnormal_systemic_arterial | 0.31324532 |
| 113 | MP0002909_abnormal_adrenal_gland | 0.31120263 |
| 114 | MP0009384_cardiac_valve_regurgitation | 0.30645937 |
| 115 | MP0002796_impaired_skin_barrier | 0.30515481 |
| 116 | MP0002970_abnormal_white_adipose | 0.30483049 |
| 117 | MP0001243_abnormal_dermal_layer | 0.30345791 |
| 118 | MP0000249_abnormal_blood_vessel | 0.30031297 |
| 119 | MP0004883_abnormal_blood_vessel | 0.28277980 |
| 120 | MP0001881_abnormal_mammary_gland | 0.27929996 |
| 121 | MP0001853_heart_inflammation | 0.27839471 |
| 122 | MP0003183_abnormal_peptide_metabolism | 0.26482703 |
| 123 | MP0001324_abnormal_eye_pigmentation | 0.26404206 |
| 124 | MP0001845_abnormal_inflammatory_respons | 0.25747255 |
| 125 | MP0005551_abnormal_eye_electrophysiolog | 0.24199093 |
| 126 | MP0002132_abnormal_respiratory_system | 0.23757383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.48262098 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.47692314 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.36296202 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.69949844 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.62319519 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.46787109 |
| 7 | Xanthomatosis (HP:0000991) | 6.29491326 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.62528135 |
| 9 | Complement deficiency (HP:0004431) | 5.34559553 |
| 10 | Joint hemorrhage (HP:0005261) | 4.82737694 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.80940410 |
| 12 | Hyperammonemia (HP:0001987) | 4.56552708 |
| 13 | Epidermoid cyst (HP:0200040) | 4.55164563 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.52359911 |
| 15 | Hyperglycinemia (HP:0002154) | 4.45229372 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.39504756 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.26391597 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.23678379 |
| 19 | Ketosis (HP:0001946) | 4.22353168 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.19736791 |
| 21 | Fat malabsorption (HP:0002630) | 4.14466549 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.08021774 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.07712962 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.90164967 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90164967 |
| 26 | Hyperglycinuria (HP:0003108) | 3.89239026 |
| 27 | Abnormality of complement system (HP:0005339) | 3.88676909 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.87221634 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.83871486 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.78500220 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.77004544 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.67282194 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.36164062 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35278690 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.29812916 |
| 36 | Spontaneous abortion (HP:0005268) | 3.17086283 |
| 37 | Steatorrhea (HP:0002570) | 3.11896507 |
| 38 | Purpura (HP:0000979) | 3.11482073 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.09007010 |
| 40 | Myocardial infarction (HP:0001658) | 3.06237328 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.05127599 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02638776 |
| 43 | Hypochromic microcytic anemia (HP:0004840) | 3.01405217 |
| 44 | Ketoacidosis (HP:0001993) | 2.98694675 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.98447842 |
| 46 | Skin nodule (HP:0200036) | 2.81399102 |
| 47 | Metabolic acidosis (HP:0001942) | 2.72429288 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.71240985 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.64708054 |
| 50 | Vascular calcification (HP:0004934) | 2.64260147 |
| 51 | Acanthocytosis (HP:0001927) | 2.57511920 |
| 52 | Lethargy (HP:0001254) | 2.55029733 |
| 53 | Mitral stenosis (HP:0001718) | 2.54363551 |
| 54 | Abnormal gallbladder morphology (HP:0012437) | 2.53845663 |
| 55 | Hypoglycemic seizures (HP:0002173) | 2.53571526 |
| 56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.52542351 |
| 57 | Dicarboxylic aciduria (HP:0003215) | 2.52542351 |
| 58 | Fair hair (HP:0002286) | 2.51847189 |
| 59 | Cholecystitis (HP:0001082) | 2.49491059 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.49491059 |
| 61 | Cholelithiasis (HP:0001081) | 2.47697960 |
| 62 | Arthropathy (HP:0003040) | 2.46184594 |
| 63 | Glomerulonephritis (HP:0000099) | 2.44210197 |
| 64 | Spastic diplegia (HP:0001264) | 2.43047396 |
| 65 | Gout (HP:0001997) | 2.39797982 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.34034414 |
| 67 | Malnutrition (HP:0004395) | 2.33355592 |
| 68 | Cerebral edema (HP:0002181) | 2.33183758 |
| 69 | Irritability (HP:0000737) | 2.32419137 |
| 70 | Amyloidosis (HP:0011034) | 2.31779758 |
| 71 | Neonatal onset (HP:0003623) | 2.30593548 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28489713 |
| 73 | Pulmonary embolism (HP:0002204) | 2.26281139 |
| 74 | Gingival bleeding (HP:0000225) | 2.26021804 |
| 75 | Joint swelling (HP:0001386) | 2.21450087 |
| 76 | Osteomalacia (HP:0002749) | 2.21229792 |
| 77 | Esophageal varix (HP:0002040) | 2.20202774 |
| 78 | Brushfield spots (HP:0001088) | 2.15187157 |
| 79 | Sensorimotor neuropathy (HP:0007141) | 2.14530239 |
| 80 | Menorrhagia (HP:0000132) | 2.13575285 |
| 81 | Late onset (HP:0003584) | 2.12978849 |
| 82 | Thrombophlebitis (HP:0004418) | 2.11812922 |
| 83 | Pancreatitis (HP:0001733) | 2.10286342 |
| 84 | Enlarged kidneys (HP:0000105) | 2.09862189 |
| 85 | Hemorrhage of the eye (HP:0011885) | 2.06565874 |
| 86 | Poikilocytosis (HP:0004447) | 2.06423739 |
| 87 | Glycosuria (HP:0003076) | 2.04977165 |
| 88 | Abnormality of urine glucose concentration (HP:0011016) | 2.04977165 |
| 89 | Abnormality of the gallbladder (HP:0005264) | 2.04561913 |
| 90 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03928469 |
| 91 | Opisthotonus (HP:0002179) | 2.03694426 |
| 92 | Vomiting (HP:0002013) | 2.02026022 |
| 93 | Gangrene (HP:0100758) | 1.99076735 |
| 94 | Generalized aminoaciduria (HP:0002909) | 1.96672093 |
| 95 | Rickets (HP:0002748) | 1.95093521 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 1.92447914 |
| 97 | Epistaxis (HP:0000421) | 1.92078341 |
| 98 | Hypophosphatemic rickets (HP:0004912) | 1.91947339 |
| 99 | Increased serum ferritin (HP:0003281) | 1.89865152 |
| 100 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89475010 |
| 101 | Renal cortical cysts (HP:0000803) | 1.86068189 |
| 102 | Abnormal cartilage morphology (HP:0002763) | 1.83154104 |
| 103 | Hydroxyprolinuria (HP:0003080) | 1.82161823 |
| 104 | Abnormality of proline metabolism (HP:0010907) | 1.82161823 |
| 105 | Status epilepticus (HP:0002133) | 1.81389303 |
| 106 | Elevated hepatic transaminases (HP:0002910) | 1.80651662 |
| 107 | Retinal atrophy (HP:0001105) | 1.80003462 |
| 108 | Abnormal biliary tract physiology (HP:0012439) | 1.78222822 |
| 109 | Bile duct proliferation (HP:0001408) | 1.78222822 |
| 110 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78055654 |
| 111 | Cerebral palsy (HP:0100021) | 1.77825977 |
| 112 | Abnormality of vitamin metabolism (HP:0100508) | 1.77793344 |
| 113 | Alkalosis (HP:0001948) | 1.75134194 |
| 114 | Hyperglycemia (HP:0003074) | 1.74882898 |
| 115 | Hyperphosphaturia (HP:0003109) | 1.74651961 |
| 116 | Reticulocytosis (HP:0001923) | 1.72727490 |
| 117 | Nephritis (HP:0000123) | 1.72379145 |
| 118 | Potter facies (HP:0002009) | 1.71480105 |
| 119 | Facial shape deformation (HP:0011334) | 1.71480105 |
| 120 | Generalized hypopigmentation of hair (HP:0011358) | 1.66443648 |
| 121 | Bifid scrotum (HP:0000048) | 1.63891843 |
| 122 | Hypothermia (HP:0002045) | 1.61750712 |
| 123 | Azoospermia (HP:0000027) | 1.61231211 |
| 124 | Reduced antithrombin III activity (HP:0001976) | 1.60488181 |
| 125 | Increased mean platelet volume (HP:0011877) | 1.59621636 |
| 126 | Abnormal tarsal ossification (HP:0008369) | 1.57029581 |
| 127 | Abnormality of the Achilles tendon (HP:0005109) | 1.54820574 |
| 128 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.51238453 |
| 129 | Increased serum pyruvate (HP:0003542) | 1.50892843 |
| 130 | Retrobulbar optic neuritis (HP:0100654) | 1.48388195 |
| 131 | Optic neuritis (HP:0100653) | 1.48388195 |
| 132 | Elevated alkaline phosphatase (HP:0003155) | 1.47399421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.90006529 |
| 2 | SIK1 | 4.66117610 |
| 3 | FGFR4 | 4.63891884 |
| 4 | ERN1 | 4.38015244 |
| 5 | WNK4 | 3.91864483 |
| 6 | TAOK3 | 3.36802662 |
| 7 | INSRR | 3.13210540 |
| 8 | ERBB4 | 3.04374294 |
| 9 | BRSK2 | 2.87023269 |
| 10 | MAP2K4 | 2.32964099 |
| 11 | NTRK3 | 2.28181429 |
| 12 | PKN2 | 2.21718374 |
| 13 | PIK3CA | 2.12136834 |
| 14 | ACVR1B | 2.10263956 |
| 15 | PDK2 | 2.08901976 |
| 16 | MST1R | 2.00400940 |
| 17 | FLT3 | 1.90974615 |
| 18 | MAPK11 | 1.89025390 |
| 19 | CASK | 1.85817252 |
| 20 | LATS1 | 1.84452321 |
| 21 | PIK3CG | 1.83261310 |
| 22 | MAP4K2 | 1.75669739 |
| 23 | TYK2 | 1.73744525 |
| 24 | TRIB3 | 1.60242677 |
| 25 | DAPK2 | 1.59776240 |
| 26 | ADRBK2 | 1.51254987 |
| 27 | BMPR1B | 1.46199191 |
| 28 | PTK6 | 1.44555249 |
| 29 | ABL2 | 1.42510150 |
| 30 | NEK9 | 1.40330274 |
| 31 | FGFR2 | 1.33711188 |
| 32 | TYRO3 | 1.32619656 |
| 33 | FRK | 1.31389619 |
| 34 | DDR2 | 1.28946453 |
| 35 | NLK | 1.28657160 |
| 36 | WNK3 | 1.28292176 |
| 37 | CAMKK2 | 1.26517741 |
| 38 | PINK1 | 1.25329905 |
| 39 | STK39 | 1.23774491 |
| 40 | MAP3K7 | 1.23245233 |
| 41 | JAK2 | 1.22987517 |
| 42 | KDR | 1.22957506 |
| 43 | TNIK | 1.22915007 |
| 44 | PRKAA2 | 1.17321891 |
| 45 | FER | 1.15628228 |
| 46 | TRIM28 | 1.14034845 |
| 47 | MATK | 1.13568724 |
| 48 | ERBB2 | 1.07308258 |
| 49 | JAK1 | 1.04072504 |
| 50 | MAP3K14 | 1.03135917 |
| 51 | LMTK2 | 1.01814410 |
| 52 | TBK1 | 0.99489024 |
| 53 | MAPK15 | 0.98314066 |
| 54 | STK38L | 0.95592499 |
| 55 | PRKCZ | 0.94852390 |
| 56 | MAP2K3 | 0.94395814 |
| 57 | MAPK4 | 0.94289844 |
| 58 | FGFR1 | 0.94257793 |
| 59 | GRK6 | 0.91891434 |
| 60 | MAP3K10 | 0.91073569 |
| 61 | STK16 | 0.89383244 |
| 62 | CAMK1D | 0.85203437 |
| 63 | IKBKB | 0.85108532 |
| 64 | GRK7 | 0.84841156 |
| 65 | MAPKAPK3 | 0.80749130 |
| 66 | MAPK12 | 0.80692926 |
| 67 | EPHA3 | 0.79363537 |
| 68 | MET | 0.78082540 |
| 69 | FGR | 0.78048928 |
| 70 | CDK6 | 0.77815006 |
| 71 | EPHB1 | 0.77161461 |
| 72 | PRKACG | 0.75780161 |
| 73 | EIF2AK1 | 0.75434976 |
| 74 | PRKAA1 | 0.74021136 |
| 75 | GRK1 | 0.73388452 |
| 76 | DYRK1B | 0.71439972 |
| 77 | MAP3K3 | 0.71100677 |
| 78 | TIE1 | 0.70579434 |
| 79 | CAMK2G | 0.69492360 |
| 80 | SGK3 | 0.69183133 |
| 81 | CSK | 0.68450459 |
| 82 | RIPK1 | 0.66537224 |
| 83 | MAP3K11 | 0.65916099 |
| 84 | PNCK | 0.63615427 |
| 85 | MAP3K13 | 0.63499311 |
| 86 | GSK3A | 0.62739997 |
| 87 | MAP2K6 | 0.61240797 |
| 88 | PRKACA | 0.61236968 |
| 89 | MAPK7 | 0.61191279 |
| 90 | IRAK3 | 0.60115385 |
| 91 | PRKG1 | 0.60031623 |
| 92 | MAP3K12 | 0.59797065 |
| 93 | CSNK1D | 0.57446963 |
| 94 | EPHA4 | 0.57211276 |
| 95 | CHUK | 0.56980530 |
| 96 | WEE1 | 0.56808200 |
| 97 | MAPKAPK5 | 0.55368327 |
| 98 | SGK2 | 0.54970133 |
| 99 | FGFR3 | 0.54796531 |
| 100 | PTK2 | 0.54033255 |
| 101 | IKBKE | 0.53455936 |
| 102 | MAP3K6 | 0.52933054 |
| 103 | CSF1R | 0.52663751 |
| 104 | MAP3K2 | 0.51262463 |
| 105 | TGFBR2 | 0.51133556 |
| 106 | BCR | 0.51111479 |
| 107 | SGK1 | 0.49654510 |
| 108 | CSNK1G1 | 0.49397301 |
| 109 | PRKCQ | 0.48814112 |
| 110 | PDPK1 | 0.47754169 |
| 111 | CSNK1E | 0.47140090 |
| 112 | TXK | 0.46918331 |
| 113 | PBK | 0.46841686 |
| 114 | ICK | 0.45917299 |
| 115 | TAOK2 | 0.45806556 |
| 116 | BRSK1 | 0.43083820 |
| 117 | IGF1R | 0.41995343 |
| 118 | MAP3K5 | 0.41665839 |
| 119 | RET | 0.41484692 |
| 120 | PRKCG | 0.40278055 |
| 121 | PKN1 | 0.40110942 |
| 122 | CDK4 | 0.39485800 |
| 123 | SGK494 | 0.38856176 |
| 124 | SGK223 | 0.38856176 |
| 125 | MAP2K1 | 0.38771174 |
| 126 | CAMK1G | 0.37267409 |
| 127 | STK3 | 0.37032233 |
| 128 | PDGFRA | 0.36657443 |
| 129 | MTOR | 0.36545571 |
| 130 | LATS2 | 0.35250136 |
| 131 | IRAK2 | 0.33216674 |
| 132 | PRKCE | 0.33029373 |
| 133 | CDC42BPA | 0.32168957 |
| 134 | CAMK4 | 0.31548060 |
| 135 | MELK | 0.30829841 |
| 136 | CSNK1A1 | 0.30698438 |
| 137 | CSNK1G2 | 0.30528441 |
| 138 | EGFR | 0.29385796 |
| 139 | PDK1 | 0.29150541 |
| 140 | MAP3K1 | 0.28288237 |
| 141 | PRKCA | 0.26389700 |
| 142 | CSNK1G3 | 0.25586958 |
| 143 | IRAK1 | 0.24762915 |
| 144 | ABL1 | 0.22123476 |
| 145 | AKT3 | 0.21280039 |
| 146 | PAK3 | 0.20676182 |
| 147 | CSNK1A1L | 0.20569700 |
| 148 | MAPK3 | 0.18280311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.53627244 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.60190507 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39369246 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36382999 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06635532 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.78103365 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.73195070 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70327902 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61120863 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54820579 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47537049 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36268313 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24568952 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14283613 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13812386 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07546905 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96503346 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93517296 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92860613 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92760123 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89622084 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85723784 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79878226 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78679309 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78633507 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75653656 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75529429 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.74256592 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69742749 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66181147 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59241892 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58055119 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55713070 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.50575176 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49726710 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49039707 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46111549 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35201423 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32281905 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31369013 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28262951 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27586824 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.24400003 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20789890 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20546893 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20546735 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15130022 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11379405 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02696964 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01875326 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00337365 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97329055 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96388022 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96037787 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91744499 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85951953 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85478816 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84156816 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.83222416 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77626887 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71416178 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67614742 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62410443 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56893132 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54691167 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.49145931 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45238329 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44723504 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42816190 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.36718590 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.33945852 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27971720 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27020429 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25059924 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.23406655 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22967670 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.21977599 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21846823 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18183507 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17775862 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10913670 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.06468240 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02337454 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.02139371 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | -0.2361843 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2349959 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2331958 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2296223 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2272004 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2270245 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2159103 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2021030 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | -0.1840926 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1822711 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1804446 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1603234 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1601166 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1503029 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1398545 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1338036 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | -0.1278739 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.1003187 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0993873 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0969198 |
| 105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0765100 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0763530 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0598876 |
| 108 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0578693 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0427029 |
| 110 | Lysosome_Homo sapiens_hsa04142 | -0.0411380 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0227520 |

